Developing computer models for combination therapy in aggressive lymphomas
Modeling and analysis of curative combination therapy for Diffuse Large B-Cell Lymphoma
This study is looking at how different combinations of drugs can work together to treat Diffuse Large B-Cell Lymphoma (DLBCL) better, using computer simulations to understand how these treatments might affect different patients and their unique tumors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11017031 on NIH RePORTER |
What this research studies
This research focuses on creating advanced computer simulations to analyze combination therapies for Diffuse Large B-Cell Lymphoma (DLBCL). By understanding how different drugs interact and how tumors respond to these treatments, the research aims to improve the design of new treatment regimens. The simulations will take into account the variability among patients and the complexity of tumors, which can differ significantly from one individual to another. This approach seeks to enhance the effectiveness of therapies by predicting how various combinations of drugs will work in diverse patient populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with Diffuse Large B-Cell Lymphoma who are seeking advanced treatment options.
Not a fit: Patients with other types of cancers or those who do not have Diffuse Large B-Cell Lymphoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with aggressive lymphomas.
How similar studies have performed: Previous research using similar modeling approaches has successfully predicted treatment responses in solid cancers, leading to multiple FDA drug approvals.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Palmer, Adam Christopher — Univ of North Carolina Chapel Hill
- Study coordinator: Palmer, Adam Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.